CD40LG and cancer: Specifically, an increase in plasma sCD40L levels was suggested as being closely associated with disease progression and the occurrence of metastasis in various cancer types, including gastric cancer [38], pancreatic cancer [39], nasopharyngeal carcinoma [40], and CRC [34].